{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T20:42:21Z","timestamp":1776458541834,"version":"3.51.2"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,11]]},"DOI":"10.7759\/cureus.38908","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:29:56Z","timestamp":1683851396000},"source":"Crossref","is-referenced-by-count":7,"title":["Metformin-Induced Acute Hepatitis"],"prefix":"10.7759","author":[{"given":"Arooj","family":"Mian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baha Aldeen","family":"Bani Fawwaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurdeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimen","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Koteish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-1-200207020-00009","article-title":"Metformin: an update","volume":"137","author":"Kirpichnikov D","year":"2002","unstructured":"Kirpichnikov D, McFarlane SI, Sowers JR. Metformin: an update. Ann Intern Med. 2002, 137:25-33. 10.7326\/0003-4819-137-1-200207020-00009","journal-title":"Ann Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.3805","article-title":"Metformin in 2019","volume":"321","author":"Flory J","year":"2019","unstructured":"Flory J, Lipska K. Metformin in 2019. JAMA. 2019, 321:1926-1927. 10.1001\/jama.2019.3805","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P099","article-title":"Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease","volume":"44","author":"Cone CJ","year":"2010","unstructured":"Cone CJ, Bachyrycz AM, Murata GH. Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease. Ann Pharmacother. 2010, 44:1655-1659. 10.1345\/aph.1P099","journal-title":"Ann Pharmacother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(98)00088-6","article-title":"Metformin-induced acute hepatitis","volume":"104","author":"Babich MM","year":"1998","unstructured":"Babich MM, Pike I, Shiffman ML. Metformin-induced acute hepatitis. Am J Med. 1998, 104:490-492. 10.1016\/S0002-9343(98)00088-6","journal-title":"Am J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S49657","article-title":"Metformin-induced mixed hepatocellular and cholestatic hepatic injury: case report and literature review","volume":"6","author":"Saadi T","year":"2013","unstructured":"Saadi T, Waterman M, Yassin H, Baruch Y. Metformin-induced mixed hepatocellular and cholestatic hepatic injury: case report and literature review. Int J Gen Med. 2013, 6:703-706. 10.2147\/IJGM.S49657","journal-title":"Int J Gen Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4158\/EP.9.4.307","article-title":"Metformin-induced cholestatic hepatitis","volume":"9","author":"Nammour FE","year":"2003","unstructured":"Nammour FE, Fayad NF, Peikin SR. Metformin-induced cholestatic hepatitis. Endocr Pract. 2003, 9:307-309. 10.4158\/EP.9.4.307","journal-title":"Endocr Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1240002","article-title":"Epidemiology of idiosyncratic drug-induced liver injury","volume":"29","author":"Bell LN","year":"2009","unstructured":"Bell LN, Chalasani N. Epidemiology of idiosyncratic drug-induced liver injury. Semin Liver Dis. 2009, 29:337-347. 10.1055\/s-0029-1240002","journal-title":"Semin Liver Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-245. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-018-0654-2","article-title":"Drug-induced liver injury: why is the Roussel Uclaf Causality Assessment Method (RUCAM) still used 25\u00a0years after its launch?","volume":"41","author":"Danan G","year":"2018","unstructured":"Danan G, Teschke R. Drug-induced liver injury: why is the Roussel Uclaf Causality Assessment Method (RUCAM) still used 25\u00a0years after its launch?. Drug Saf. 2018, 41:735-743. 10.1007\/s40264-018-0654-2","journal-title":"Drug Saf"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/152419-metformin-induced-acute-hepatitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:00:03Z","timestamp":1707508803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/152419-metformin-induced-acute-hepatitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.38908","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,11]]}}}